Lifeward

Company Overview

Snapshot

Founded in June 2001, Lifeward operates with 11–50 employees and has raised over $257.92 million across 22 funding rounds from 12 investors. The company went public on NASDAQ in September 2014 and secured growth capital in July 2026.

Business overview

Lifeward is dedicated to innovating solutions that enhance the lives of individuals with physical limitations or disabilities. The company develops and delivers groundbreaking products, including the ReWalk Exoskeleton, ReStore Exo-Suit, MYOLYN FES bikes, and AlterG Anti-Gravity systems. Operating within the Health Tech & Life Sciences sector, Lifeward serves markets globally with its medical devices and assistive technologies, focusing on rehabilitation, orthopedics, and digital healthcare.

Strategic signal

In July 2026, Lifeward secured growth capital with up to $11.2 million in strategic financing, led by Oramed Pharmaceuticals. This investment signals continued confidence in Lifeward's market leadership and its potential to expand commercial operations, reinforcing its trajectory as a key innovator in assistive medical devices.

Company Intelligence Q&A

What was a significant recent financial event for Lifeward?

In July 2026, Lifeward secured growth capital with up to $11.2 million in strategic financing, with Oramed Pharmaceuticals as a lead investor.

When did Lifeward go public?

Lifeward went public on NASDAQ in September 2014, raising $36 million in its Initial Public Offering with a valuation of $136 million.

What was a key acquisition made by Lifeward?

In August 2023, Lifeward acquired AlterG, a move aimed at enhancing its product portfolio and profitability.

What was a notable product development for ReWalk Robotics?

In May 2026, Lifeward announced new ReWalk data presented at the ASIA 2026 Conference, demonstrating a comprehensive longitudinal safety analysis for a powered exoskeleton.

What was a significant regulatory milestone for ReWalk Robotics?

In October 2020, ReWalk Robotics received Medicare Provider Certification, a crucial step for broader accessibility and reimbursement of its devices.